Treating patients with schizophrenia deficit with erythropoietin?
about
A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.The promise of biological markers for treatment response in first-episode psychosis: a systematic review.Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.Emerging drugs for schizophrenia: an update.Erythropoietin Induces Homeostatic Plasticity at Hippocampal Synapses.Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
P2860
Treating patients with schizophrenia deficit with erythropoietin?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treating patients with schizophrenia deficit with erythropoietin?
@en
type
label
Treating patients with schizophrenia deficit with erythropoietin?
@en
prefLabel
Treating patients with schizophrenia deficit with erythropoietin?
@en
P2093
P2860
P50
P1476
Treating patients with schizophrenia deficit with erythropoietin?
@en
P2093
Alexandra Macgregor
Aurore Larue
Jérome Attal
Marie Brittner
P2860
P304
P356
10.1111/J.1440-1819.2012.02359.X
P577
2012-06-22T00:00:00Z